Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CING
#4240
Cingulate Inc. Common Stock
5.349
0
USD
-0.02%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.02%
Monthly Change
-46.02%
6 month change
-13.17%
Year Change
-13.17%
Previous Close
5.350
0
Open
5.380
0
Bid
Ask
Low
5.310
0
High
5.400
0
Volume
37
Markets
US Stock Market
Healthcare
CING
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
47.12 K
47.12 K
417.54 K
3.77 M
11.63 M
—
Valuation ratios
Enterprise value
15.85 M
12.01 M
36.21 M
11.34 M
46.96 M
102.57 M
Price to earnings ratio
—
-0.65
-0.26
-0.48
-0.98
5.46
Price to sales ratio
—
—
—
—
-10.12
—
Price to cash flow ratio
—
-0.73
-0.4
-0.41
-1.27
-2.98
Price to book ratio
—
2.97
-0.89
1.01
8.74
9.72
Enterprise value to EBITDA ratio
—
—
—
—
-3.84
—
Profitability ratios
Return on assets %
-0.9
-1.55
-6.74
-1.05
-1.49
-1.77
Return on equity %
-0.99
-4.55
3.43
-2.09
-8.95
-6.12
Return on invested capital %
-1 496.72
-971.12
-1 199.49
-1 123.26
-1 103.5
-1 119.32
Gross margin %
—
—
—
—
100
—
Operating margin %
—
—
—
—
920.04
—
EBITDA margin %
—
—
—
—
580.03
—
Net margin %
—
—
—
—
1 035.95
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
16.05
1.12
0.06
2.55
1.16
5.82
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
-0.14
—
Solvency ratios
Debt to assets ratio
0.05
0.51
0.74
0.33
0.49
1.58
Debt to equity ratio
0.05
1.5
-0.38
0.67
2.97
5.67
Long term debt to total assets ratio
0
0.44
0.6
0.33
0.49
1.58
Long term debt to total equity ratio
0
1.29
-0.31
0.67
2.97
5.67
Per share metrics
Operating cash flow per share
—
-337.05
-199.3
-12.1
-3.41
-3.85
EBIT per share
—
—
—
—
-2.6
—
EBITDA per share
—
—
—
—
-2.49
—
Total debt per share
—
123.69
34.32
3.26
1.47
4.61
Cash per share
—
113.67
0.69
8.01
2.17
7.93
Net current asset value per share
—
167
7.67
8.3
2.38
8.95
Tangible book value per share
—
82.38
-91.06
4.89
0.5
4.02
Working capital per share
—
18.18
-127.89
5.04
0.34
2.76
Book value per share
—
82.38
-91.06
4.89
0.5
4.02
News
Cingulate increases at-the-market offering limit to $31.9 million
Cingulate reinstates Shane Schaffer as CEO, updates employment terms
Cingulate appoints new CCO, secures $6 million financing
Cingulate’s ADHD drug meets primary endpoints in phase 3 trial
FDA accepts Cingulate’s ADHD drug application, sets May 2026 target date
Cingulate secures manufacturing deal with Bend Bio Sciences for ADHD drug
Cingulate issues shares to lender in series of unregistered transactions
Cingulate appoints John A. Roberts as executive chairman, CEO placed on leave
Ascendiant Capital raises Cingulate stock price target to $62 from $61
Cingulate Posts Wider Loss in Q2
Cingulate places CEO on leave, appoints interim leadership
Cingulate submits NDA for ADHD treatment to FDA